Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Project Inform perspective

Showing results (141-150 of 280) with videos related to

Pageof 28
Sort By:
Project Inform Perspective|May 22, 2001
Advances in CMV management: fomivirsen (Vitravene) approved
Project Inform Perspective|May 22, 2001
Nevirapine in children
Project Inform Perspective|May 22, 2001
Report from the HAARTland
Project Inform Perspective|May 22, 2001
Gender difference in Nevirapine-associated rash
Project Inform Perspective|May 22, 2001
Pulsed therapy and structured interruptions of treatment
Project Inform Perspective|May 22, 2001
Opportunistic infections update
Project Inform Perspective|May 22, 2001
Third line therapy options
Project Inform Perspective|May 22, 2001
The fine line between education and marketing
Project Inform Perspective|May 22, 2001
A new acronym, a new threat: IRU
Project Inform Perspective|May 22, 2001
Advances in research: second and third line therapy
Pageof 28

Showing results (141-150 of 280) with videos related to

Sort By:
Pageof 28
Project Inform Perspective|May 22, 2001
Advances in CMV management: fomivirsen (Vitravene) approved
Project Inform Perspective|May 22, 2001
Nevirapine in children
Project Inform Perspective|May 22, 2001
Report from the HAARTland
Project Inform Perspective|May 22, 2001
Gender difference in Nevirapine-associated rash
Project Inform Perspective|May 22, 2001
Pulsed therapy and structured interruptions of treatment
Project Inform Perspective|May 22, 2001
Opportunistic infections update
Project Inform Perspective|May 22, 2001
Third line therapy options
Project Inform Perspective|May 22, 2001
The fine line between education and marketing
Project Inform Perspective|May 22, 2001
A new acronym, a new threat: IRU
Project Inform Perspective|May 22, 2001
Advances in research: second and third line therapy
Pageof 28